Processing Tissue Micro-Array Images Using Machine Learning Techniques as Preparation for Determining Gleason Grade of Prostate Cancer. - Zihan Xiong; Yixuan Zheng; Jiayue Qiu (ICBRA, 2021)

CNA2Subpathway: identification of dysregulated subpathway driven by copy number alterations in cancer. - Yuqi Sheng; Ying Jiang; Yang Yang 009; Xiangmei Li; Jiayue Qiu; Jiashuo Wu; Liang Cheng 006; Junwei Han 003 (Briefings Bioinform., 2021)

A novel pathway mutation perturbation score predicts the clinical outcomes of immunotherapy. - Xiangmei Li; Yalan He; Jiashuo Wu; Jiayue Qiu; Ji Li; Qian Wang; Ying Jiang; Junwei Han 003 (Briefings Bioinform., 2022)

UCM: Personalized Document-Level Sentiment Analysis Based on User Correlation Mining. - Jiayue Qiu; Ziyue Yu; Wuman Luo (ICIC (4), 2023)

iATMEcell: identification of abnormal tumor microenvironment cells to predict the clinical outcomes in cancer based on cell-cell crosstalk network. - Yuqi Sheng; Jiashuo Wu; Xiangmei Li; Jiayue Qiu; Ji Li; Qinyu Ge; Liang Cheng 006; Junwei Han 003 (Briefings Bioinform., 2023)

3DSGIMD: An accurate and interpretable molecular property prediction method using 3D spatial graph focusing network and structure-based feature fusion. - Yanan Tian; Chenbin Wang; Ruiqiang Lu; Henry H. Y. Tong; Xiaoqing Gong; Jiayue Qiu; Shaoliang Peng; Xiaojun Yao; Huanxiang Liu (Future Gener. Comput. Syst., 2024)

A survey on personalized document-level sentiment analysis. - Wenhao Zhu; Jiayue Qiu; Ziyue Yu; Wuman Luo (Neurocomputing, 2024)

Evaluation of AlphaFold2 Structures for Hit Identification across Multiple Scenarios. - Shukai Gu; Yuwei Yang; Yihao Zhao; Jiayue Qiu; Xiaorui Wang; Henry Hoi Yee Tong; Liwei Liu; Xiaozhe Wan; Huanxiang Liu; Tingjun Hou; Yu Kang 002 (J. Chem. Inf. Model., 2024)

A Specialized and Enhanced Deep Generation Model for Active Molecular Design Targeting Kinases Guided by Affinity Prediction Models and Reinforcement Learning. - Xiaomeng Liu; Qin Li; Xiao Yan; Lingling Wang; Jiayue Qiu; Xiaojun Yao; Huanxiang Liu (J. Chem. Inf. Model., 2025)